Kwantlen Polytechnic University has withdrawn from Manulife’s DrugWatch program after an instructor filed a human rights complaint alleging that the program prevented them from accessing a “life-changing” medication for over a year. CBC reports that the complaint names KPU President Alan Davis and VP of Human Resources Laurie Clancy as respondents. According to CBC, the Kwantlen Faculty Association (KFA) also called the program discriminatory, unfair, and “ethically questionable” last year. “While Manulife has assured the University that no KPU faculty member was denied access to medication after it re-entered DrugWatch, the university has listened to faculty concerns raised through the offices of the Kwantlen Faculty Association,” read a statement from Clancy and KFA President Mark Diotte.
